Pharmaceutical giant says new propellant has a global warming potential 99.9 per cent lower than those used in conventional inhalers
Efforts to replace medical inhalers with near-zero emission alternatives have taken a major step forward, with pharmaceutical giant AstraZeneca today announcing it has completed the clinical programme...
To continue reading this article...
Join BusinessGreen
In just a few clicks you can start your free BusinessGreen Lite membership for 12 months, providing you access to:
- Three complimentary articles per month covering the latest real-time news, analysis, and opinion from Europe’s leading source of information on the Green economy and business
- Receive important and breaking news stories via our daily news alert
- Our weekly newsletter with the best of the week’s green business news and analysis
